Nicorandil Improves Glomerular Injury in Rats With Mesangioproliferative Glomerulonephritis via Inhibition of Proproliferative and Profibrotic Growth Factors
-
- Sudo Hirokazu
- Product Research Department, Chugai Pharmaceutical Co., Ltd., Japan
-
- Hirata Michinori
- Product Research Department, Chugai Pharmaceutical Co., Ltd., Japan
-
- Kanada Hirotaka
- Product Research Department, Chugai Pharmaceutical Co., Ltd., Japan
-
- Yorozu Keigo
- Product Research Department, Chugai Pharmaceutical Co., Ltd., Japan
-
- Tashiro Yoshihito
- Product Research Department, Chugai Pharmaceutical Co., Ltd., Japan
-
- Serizawa Ken-ichi
- Product Research Department, Chugai Pharmaceutical Co., Ltd., Japan
-
- Yogo Kenji
- Product Research Department, Chugai Pharmaceutical Co., Ltd., Japan
-
- Kataoka Motoyuki
- Product Research Department, Chugai Pharmaceutical Co., Ltd., Japan
-
- Moriguchi Yoshiyuki
- Product Research Department, Chugai Pharmaceutical Co., Ltd., Japan
-
- Ishizuka Nobuhiko
- Product Research Department, Chugai Pharmaceutical Co., Ltd., Japan
この論文をさがす
抄録
Recent clinical studies on chronic kidney disease (CKD) reported that renal dysfunction was a critical risk factor for cardiovascular events (CVE), which lead us to reconsider the effect of cardioprotective agents on the kidney. Glomerulonephritis, which is the major cause of CKD, is characterized by mesangial cell proliferation and extracellular matrix deposition. Nicorandil, a therapeutic drug for angina and acute heart failure, have been reported to show antiproliferative activity in mesangial cells. In this study, we first investigated the in vivo effects of nicorandil in anti-Thy1 nephritis rats. In male F344 rats, anti-Thy1 nephritis was induced by the injection of an anti-Thy1 antibody. From three days before induction, nicorandil (10, 30 mg/kg per day) was administered in the drinking water for 12 consecutive days. Anti-Thy1 nephritis resulted in a significant increase in proteinuria and glomerular mesangial cell proliferation. In nephritis rats, nicorandil (30 mg/kg per day) significantly suppressed increase in proteinuria, mesangial cell proliferation (the number of glomerular cell and glomerular area), and renal hypertrophy without affecting blood pressure. Nicorandil significantly prevented the overexpression of type I collagen, fibronectin, transforming growth factor (TGF)-β, and platelet-derived growth factor (PDGF) mRNA. These results suggest that nicorandil may have renoprotective effects in mesangioproliferative glomerulonephritis.<br>
収録刊行物
-
- Journal of Pharmacological Sciences
-
Journal of Pharmacological Sciences 111 (1), 53-59, 2009
公益社団法人 日本薬理学会
- Tweet
詳細情報 詳細情報について
-
- CRID
- 1390001205179561728
-
- NII論文ID
- 10025738636
-
- NII書誌ID
- AA11806667
-
- ISSN
- 13478648
- 13478613
-
- NDL書誌ID
- 10370220
-
- 本文言語コード
- en
-
- データソース種別
-
- JaLC
- NDL
- Crossref
- CiNii Articles
-
- 抄録ライセンスフラグ
- 使用不可